These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 2879636)

  • 1. Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells.
    Knabbe C; Lippman ME; Wakefield LM; Flanders KC; Kasid A; Derynck R; Dickson RB
    Cell; 1987 Feb; 48(3):417-28. PubMed ID: 2879636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth regulatory peptide production by human breast carcinoma cells.
    Lippman ME; Dickson RB; Gelmann EP; Rosen N; Knabbe C; Bates S; Bronzert D; Huff K; Kasid A
    J Steroid Biochem; 1988; 30(1-6):53-61. PubMed ID: 3290584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
    Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
    Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and oncogene mediated growth regulation of human breast cancer cells.
    Kasid A; Lippman ME
    J Steroid Biochem; 1987; 27(1-3):465-70. PubMed ID: 3501040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of transforming growth factor-beta signaling does not abrogate antiestrogen-induced growth inhibition of human breast carcinoma cells.
    Koli KM; Ramsey TT; Ko Y; Dugger TC; Brattain MG; Arteaga CL
    J Biol Chem; 1997 Mar; 272(13):8296-302. PubMed ID: 9079651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of transforming growth factor beta by the antiestrogens droloxifene, tamoxifen, and toremifene in MCF-7 cells.
    Knabbe C; Zugmaier G; Schmahl M; Dietel M; Lippman ME; Dickson RB
    Am J Clin Oncol; 1991; 14 Suppl 2():S15-20. PubMed ID: 1835818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
    Herman ME; Katzenellenbogen BS
    Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
    Arteaga CL; Coffey RJ; Dugger TC; McCutchen CM; Moses HL; Lyons RM
    Cell Growth Differ; 1990 Aug; 1(8):367-74. PubMed ID: 2177634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of colon and breast carcinoma cell growth by interleukin-4.
    Toi M; Bicknell R; Harris AL
    Cancer Res; 1992 Jan; 52(2):275-9. PubMed ID: 1728401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of transforming growth factor alpha and its messenger ribonucleic acid in human breast cancer: its regulation by estrogen and its possible functional significance.
    Bates SE; Davidson NE; Valverius EM; Freter CE; Dickson RB; Tam JP; Kudlow JE; Lippman ME; Salomon DS
    Mol Endocrinol; 1988 Jun; 2(6):543-55. PubMed ID: 3047554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells.
    Gong Y; Ballejo G; Murphy LC; Murphy LJ
    Cancer Res; 1992 Apr; 52(7):1704-9. PubMed ID: 1551100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of the epidermal growth factor receptor inhibits transforming growth factor alpha-induced but not estrogen-induced growth of hormone-dependent human breast cancer.
    Arteaga CL; Coronado E; Osborne CK
    Mol Endocrinol; 1988 Nov; 2(11):1064-9. PubMed ID: 3221874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions.
    Murphy CS; Pink JJ; Jordan VC
    Cancer Res; 1990 Nov; 50(22):7285-92. PubMed ID: 2224859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of MCF-7ras tumor growth by carboxymethyl benzylamide dextran: blockage of the paracrine effect and receptor binding of transforming growth factor beta1 and platelet-derived growth factor-BB.
    Bagheri-Yarmand R; Kourbali Y; Morère JF; Jozefonvicz J; Crépin M
    Cell Growth Differ; 1998 Jun; 9(6):497-504. PubMed ID: 9663468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial antagonism between steroidal and nonsteroidal antiestrogens in human breast cancer cell lines.
    Müller V; Jensen EV; Knabbe C
    Cancer Res; 1998 Jan; 58(2):263-7. PubMed ID: 9443403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of expression of three transforming growth factor beta species in human breast cancer cell lines by estradiol.
    Arrick BA; Korc M; Derynck R
    Cancer Res; 1990 Jan; 50(2):299-303. PubMed ID: 2295070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of epidermal growth factor/transforming growth factor-alpha-stimulated cell growth by a synthetic peptide.
    Eppstein DA; Marsh YV; Schryver BB; Bertics PJ
    J Cell Physiol; 1989 Nov; 141(2):420-30. PubMed ID: 2530243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha enhances secretion of transforming growth factor beta2 in MCF-7 breast cancer cells.
    Danforth DN; Sgagias MK
    Clin Cancer Res; 1996 May; 2(5):827-35. PubMed ID: 9816237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor beta secretion from primary breast cancer fibroblasts.
    van Roozendaal CE; Klijn JG; van Ooijen B; Claassen C; Eggermont AM; Henzen-Logmans SC; Foekens JA
    Mol Cell Endocrinol; 1995 Apr; 111(1):1-6. PubMed ID: 7649348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth modulatory effects of a liver-derived growth inhibitor, transforming growth factor beta 1, and recombinant tumor necrosis factor alpha, in normal and neoplastic cells.
    Chapekar MS; Huggett AC; Thorgeirsson SS
    Exp Cell Res; 1989 Nov; 185(1):247-57. PubMed ID: 2806409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.